1. Elevated NLR May Be a Feature of Pediatric Brain Cancer Patients
   Michal Yalon et al, 2019, Front. Oncol. CrossRef
2. Application of Cancer Organoid Model for Drug Screening and Personalized Therapy.
   Jumpei Kondo et al, 2019, Cells CrossRef
3. Siah2 control of T-regulatory cells limits anti-tumor immunity
   Marzia Scortegagna et al, 2020, Nat Commun CrossRef
4. Androgen receptor affects the response to immune checkpoint therapy by suppressing PD-L1 in hepatocellular carcinoma
   Guangyi Jiang et al, 2020, Aging CrossRef
5. Adenovirus-Mediated Inducible Expression of a PD-L1 Blocking Antibody in Combination with Macrophage Depletion Improves Survival in a Mouse Model of Peritoneal Carcinomatosis
   Maria Buñuales et al, 2021, IJMS CrossRef
6. TIGIT Induces (CD3+) T Cell Dysfunction in Colorectal Cancer by Inhibiting Glucose Metabolism
   Qi Shao et al, 2021, Front. Immunol. CrossRef
7. Equipping Cancer Cell Membrane Vesicles with Functional DNA as a Targeted Vaccine for Cancer Immunotherapy
   Bo Liu et al, 2021, Nano Lett. CrossRef
8. Type I Interferon Promotes Antitumor T Cell Response in CRPC by Regulating MDSC
   Lilv Fan et al, 2021, Cancers CrossRef
9. null
   Anubhab Mukherjee et al, 2021 CrossRef
10. Engineered DBCO+PD-1 Nanovesicles Carrying 1-MT for Cancer-Targeted Immunotherapy
    Xichao Xu et al, 2022, ACS Biomater. Sci. Eng. CrossRef